Home 2021-05-05T17:08:30-04:00

Klox Technologies

Klox Technologies Inc. is a private regenerative medicine company, advancing the development of its proprietary Fluorescent Light Energy (FLE) platform, also known as Fluorescence Biomodulation, for specific skin/soft tissue conditions and diseases. Our platform has shown to impact cellular signaling pathways, which stimulate the skin’s own biological processes and repair mechanisms. At our core we research, develop, and partner our proprietary products for a growing population that is seeking a high degree of clinical effectiveness, while being less invasive, safe and cost effective.

Explore our Technology

Klox’s products are applied topically to the skin and are subsequently illuminated by an LED activator for a short period of under 10 minutes. The topical is not required to be metabolized or internalized by the skin prior to the illumination.

The LED activator’s emission interacts with specialized molecules embedded within Klox’s topical product to generate a unique emission of fluorescent light energy. Klox utilizes this unique emission to target diseases and conditions affecting the skin and soft tissues.

Fluorescent light energy is a form of photobiomodulation, which utilizes fluorescence energy to induce multiple transduction pathways that can modulate biological processes through the activation of photoacceptors found within many different cell and tissue types.  Read more.

About Us

Klox Technologies Inc. is a private regenerative medicine company, advancing the development of its FLE platform, also known as Fluorescence Biomodulation, for specific skin/soft tissue conditions and diseases. We believe in providing healthcare professionals with novel and effective treatment solutions, which in turn allow patients to experience positive results without extensive side effects or high costs associated with existing standard of care treatments.

Trusted Collaborators

At Klox, we always strive to build and invest in our science, technology, and engineering expertise. To challenge the conventions of the industry, we extend our capabilities by collaborating with leading professionals and cutting-edge scientific facilities, wherever they may be. Our extended network is critical for maintaining vitality and scientific rigor in our mission to bring out unique product offerings to patients in need.

News & Events

December 12, 2019

December 12, 2019

October 29, 2019

October 27-29, 2019

Targeting Mitochondria Congress – Berlin, Germany

October 22-23, 2019

The International Scar Club Meeting – Montpellier, France

October 8, 2019

Klox Technologies Inc. announces the appointment of Mr. Domenic Serafino and Dr. Richard Markoff to its board of directors – See Full Press Release here

October 4, 2019

Klox Technologies Inc. Announces Completion of the Acquisition of FB Dermatology – See Full Press Release here

September 26-28, 2019

September 23-25, 2019

The MedTech Conference – Boston, United States

August 30, 2019

August 19-22, 2019

Military Health System Research Symposium – Florida, United States

August 13, 2019

June 10-15, 2019

June 5-7, 2019

May 16-17, 2019

VetCon – Cork, Ireland

May 3-4, 2019

March 20-21, 2019

March 15-17, 2019

La Chirurgia Estetica– Florence, Italy

March 8, 2019

March 7, 2019

LumiHeal was granted the Canadian Medical Device License (MDL) for “the management of post-surgical closed wounds and to help in the prevention of hypertrophic scars and post-surgical wound complications in patients 18 years and older”

March 1, 2019

Fluorescence Biomodulation has been added to various sections in the Journal of Wound Care’s 2019 peer-reviewed International Consensus Document – Implementing TIMERS: the race against hard-to-heal wounds

February 26-27, 2019

Animal Health Investment Europe – London, England

February 2-7, 2019

SPIE Photonics West – San Francisco, USA

January 30, 2019

LumiHeal Newsletter – Updates On Our Lead Wound Care Product

January 20-22, 2019

Journées Cicatrisations – Paris, France

January 7-10, 2019

J.P. Morgan Healthcare Conference – San Francisco, USA

November 5-7, 2018

Wounds UK – Harrogate, UK

November 4, 2018

September 24-26, 2018

The MedTech Conference – Philadelphia, USA

September 12-14, 2018

July 2, 2018

Klox announces positive top-line results from a pivotal study of Phovia™ for the management of Canine Deep Pyoderma – See Full Press Release

June 13-14, 2018

June 4-7, 2018

May 9-11, 2018

May 2-3, 2018

April 25-29, 2018